North Island Credit Union Partners with North County African American Women's Association to Award Four College Scholarships   •   GE HealthCare Technologies Inc. Prices Secondary Offering of 25,000,000 Shares   •   World's first women's polo club set to open at Chongqing Fairy Mountain   •   PPG’s New Paint for a New Start initiative to beautify schools worldwide with colorful makeovers   •   Paralyzed Veterans of America issues statement urging Congress act now to remove barriers that prevent disabled Veterans from ac   •   U.S. News & World Report Names Watercrest Myrtle Beach a 2023-24 Best Assisted Living Community   •   Cyber Dive's Aqua One smartphone plays an integral role in transitioning survivors through the Phoenix Dream Center's Human Traf   •   Value(s) Management and Investing and Greenspoon Marder LLP Globally Expand Corporate, Corporate Governance, Investment and ESG   •   Liberty HealthShare at Church of the Nazarene General Assembly   •   Hospitals Score Another Massive Victory Against the Blues as Court Rejects Insurance Companies’ Second Attempt to Dismiss   •   Blue Bird Announces Pricing of Secondary Public Offering   •   Renee Parsons Hosts 3rd Annual PXG Women's Day to Play: A Company Wide Golf Experience In Celebration of PXG's Female Employees   •   NASA Awards $5 Million to Women's Colleges Tackling STEM Gender Gap   •   EpimAb Biotherapeutics Appoints Yonghong Zhu, M.D., Ph.D., as Chief Medical Officer   •   SENTINELONE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against SentinelOne, Inc   •   SENTINELONE SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in   •   Climate Impact X Launches CIX Exchange to Level up Carbon Market Transparency, Certainty and Liquidity   •   Vertex Energy Announces Key Step in Strengthening Balance Sheet Position with Private Exchange of Approximately $79.95 Million o   •   Two FirstEnergy Employees Named Women of Professional Excellence by YWCA of Greater Cleveland   •   Immune-Onc Therapeutics Presents IO-202 Phase 1 Data in Patients with Relapsed or Refractory AML and CMML at the EHA Annual Meet